16880 Federal Register / Vol. 60, No. 63 / Monday, April 3, 1995 / Notices

National Institute of Mental Health

which was published in the Federal

Register on March 3, 1995 (60 FR

11976): the Extramural Science

Advisory Board, April 24–25, 1995,

Conference Room 10, Building 31,

National Institutes of Health, 9000

Rockville Pike, Bethesda, MD 20892.

The meeting was cancelled due to

prior commitments of several members.

Dated: March 28, 1995.

Susan K. Feldman,

Committee Management Officer, NIH.

[FR Doc. 95–8120 Filed 3–31–95; 8:45 am]

BILLING CODE 4140–01–M

Ad Hoc Review Committee for the

Recombinant DNA Advisory

Committee; Notice of Meeting

Notice is hereby given of a meeting of

the Ad Hoc Review Committee for the

Recombinant DNA Advisory Committee

on May 1, 1995, at the National

Institutes of Health, Building 31C, 6th

Floor, Conference Room 8, 9000

Rockville Pike, Bethesda, Maryland

20892, starting at approximately 9 a.m.

to adjournment at approximately 5 p.m.

The meeting will be open to the public

to discuss three major topics for review:

(1) Domain and mandate of the

Recombinant DNA Advisory Committee;

(2) composition of the Recombinant

DNA Advisory Committee; and (3)

Recombinant DNA Advisory

Committee’s review of human gene

transfer protocols. Members of the

public wishing to speak at this meeting

may be given such opportunity at the

discretion of the Chair.

Dr. Nelson A. Wivel, Director, Office

of Recombinant DNA Activities, Suite

323, National Institutes of Health, 6006

Executive Boulevard, MSC 7052,

Bethesda, Maryland 20892–7052, phone

(301) 496–9838, FAX (301) 496–9839,

will provide materials to be discussed at

this meeting, roster of committee

members, and substantive program

information. Individuals who plan to

attend and need special assistance, such

as sign language interpretation or other

reasonable accommodations, should

contact Dr. Wivel in advance of the

meeting. A summary of the meeting will

be available at a later date.

OMB’s ‘‘Mandatory Information

Requirements for Federal Assistance

Program Announcements’’ (45 FR

39592, June 11, 1980) requires a

statement concerning the official

government programs contained in the

Catalog of Federal Domestic Assistance.

Normally NIH lists in its

announcements the number and title of

affected individual programs for the

guidance of the public. Because the

guidance in this notice covers not only

virtually every NIH program but also

essentially every Federal research

program in which DNA recombinant

molecule techniques could be used, it

has been determined not to be cost

effective or in the public interest to

attempt to list these programs. Such a

list would likely require several

additional pages. In addition, NIH could

not be certain that every Federal

program would be included as many

Federal agencies, as well as private

organizations, both national and

international, have elected to follow the

NIH Guidelines. In lieu of the

individual program listing, NIH invites

readers to direct questions to the

information address above about

whether individual programs listed in

the Catalog of Federal Domestic

Assistance are affected.

Dated: March 28, 1995.

Susan K. Feldman,

Committee Management Officer, NIH.

[FR Doc. 95–8121 Filed 3–31–95; 8:45 am]

BILLING CODE 4140–01–M

Division of Research Grants; Notice of

Meeting of the Division of Research

Grants Advisory Committee

Pursuant to Pub. L. 92–463, notice is

hereby given of the meeting of the

Division of Research Grants Advisory

Committee, May 8–9, 1995, Building

31C, Conference Room 6, National

Institutes of Health, 9000 Rockville

Pike, Bethesda, Maryland 20892.

The entire meeting will be open to the

public from 8:30 a.m. on May 8 to

adjournment on May 9. The topics for

the meeting will include, among others,

the recommendations of the Clinical

Research Study Group and the Survey of

Science Workshop. Attendance by the

public will be limited to space available.

The Office of Committee

Management, Division of Research

Grants, Westwood Building, Room 433,

National Institutes of Health, Bethesda,

Maryland 20892, telephone (301) 594–

7265, will furnish a summary of the

meeting and a roster of the committee

members.

Dr. Samuel Joseloff, Executive

Secretary of the Committee, Westwood

Building, Room 449, National Institutes

of Health, Bethesda, Maryland 20892,

phone (301) 594–7248, will provide

substantive program information upon

request.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

contact the Executive Secretary at least

two weeks in advance of the meeting.

Dated: March 28, 1995.

Susan K. Feldman,

Committee Management Officer, NIH.

[FR Doc. 95–8122 Filed 3–31–95; 8:45 am]

BILLING CODE 4140–01–M

Substance Abuse and Mental Health

Services Administration

Current List of Laboratories Which

Meet Minimum Standards To Engage in

Urine Drug Testing for Federal

Agencies and Laboratories That Have

Withdrawn From the Program

AGENCY: Substance Abuse and Mental

Health Services Administration, HHS.

(Formerly: National Institute on Drug

Abuse, ADAMHA, HHS).

ACTION: Notice.

SUMMARY: The Department of Health and

Human Services notifies Federal

agencies of the laboratories currently

certified to meet standards of Subpart C

of Mandatory Guidelines for Federal

Workplace Drug Testing Programs (59

FR 29916, 29925). A similar notice

listing all currently certified laboratories

will be published during the first week

of each month, and updated to include

laboratories which subsequently apply

for and complete the certification

process. If any listed laboratory’s

certification is totally suspended or

revoked, the laboratory will be omitted

from updated lists until such time as it

is restored to full certification under the

Guidelines.

If any laboratory has withdrawn from

the National Laboratory Certification

Program during the past month, it will

be identified as such at the end of the

current list of certified laboratories, and

will be omitted from the monthly listing

thereafter.

FOR FURTHER INFORMATION CONTACT: Mrs.

Giselle Hersh, Division of Workplace

Programs, Room 13A–54, 5600 Fishers

Lane, Rockville, Maryland 20857; Tel.:

(301) 443–6014.

SUPPLEMENTARY INFORMATION:

Mandatory Guidelines for Federal

Workplace Drug Testing were developed

in accordance with Executive Order

12564 and section 503 of Pub. L. 100–

71. Subpart C of the Guidelines,

‘‘Certification of Laboratories Engaged

in Urine Drug Testing for Federal

Agencies,’’ sets strict standards which

laboratories must meet in order to

conduct urine drug testing for Federal

agencies. To become certified an

applicant laboratory must undergo three

rounds of performance testing plus an

on-site inspection. To maintain that

certification a laboratory must

participate in a quarterly performance
Federal Register / Vol. 60, No. 63 / Monday, April 3, 1995 / Notices 16881

testing program plus periodic, on-site

inspections.

Laboratories which claim to be in the

applicant stage of certification are not to

be considered as meeting the minimum

requirements expressed in the HHS

Guidelines. A laboratory must have its

letter of certification from SAMHSA,

HHS (formerly: HHS/NIDA) which

attests that it has met minimum

standards.

In accordance with Subpart C of the

Guidelines, the following laboratories

meet the minimum standards set forth

in the Guidelines:

ACCU-LAB, Inc., 405 Alderson St.,

Schofield, WI 54476, 800–627–8200,

(formerly: Alpha Medical Laboratory,

Inc., Employee Health Assurance

Group, ExpressLab, Inc.).

Aegis Analytical Laboratories, Inc., 624

Grassmere Park Rd., Suite 21,

Nashville, TN 37211, 615–331–5300.

Alabama Reference Laboratories, Inc.,

543 South Hull St., Montgomery, AL

36103, 800–541–4931/205–263–5745.

American Medical Laboratories, Inc.,

14225 Newbrook Dr., Chantilly, VA

22021, 703–802–6900.

Associated Pathologists Laboratories,

Inc., 4230 South Burnham Ave., Suite

250, Las Vegas, NV 89119–5412, 702–

733–7866.

Associated Regional and University

Pathologists, Inc. (ARUP), 500 Chipeta

Way, Salt Lake City, UT 84108, 801–

583–2787.

Baptist Medical Center—Toxicology

Laboratory, 9601 I–630, Exit 7, Little

Rock, AR 72205–7299, 501–227–2783

(formerly: Forensic Toxicology

Laboratory Baptist Medical Center).

Bayshore Clinical Laboratory, 4555 W.

Schroeder Dr., Brown Deer, WI 53223,

414–355–4444/800–877–7016.

Cedars Medical Center, Department of

Pathology, 1400 Northwest 12th Ave.,

Miami, FL 33136, 305–325–5810.

Centinela Hospital Airport Toxicology

Laboratory, 9601 S. Sepulveda Blvd.,

Los Angeles, CA 90045, 310–215–

6020.

Clinical Reference Lab, 11850 West 85th

St., Lenexa, KS 66214, 800–445–6917.

CORNING Clinical Laboratories, South

Central Divison, 2320 Schuetz Rd., St.

Louis, MO 63146, 800–288–7293

(formerly: Metropolitan Reference

Laboratories, Inc.).

CORNING Clinical Laboratories, 8300

Esters Blvd., Suite 900, Irving, TX

75063, 800–526–0947, (formerly:

Damon Clinical Laboratories, Damon/

MetPath).

CORNING MetPath Clinical

Laboratories, 1355 Mittel Blvd., Wood

Dale, IL 60191, 708–595–3888,

(formerly: MetPath, Inc.).

CORNING MetPath Clinical

Laboratories, One Malcolm Ave.,

Teterboro, NJ 07608, 201–393–5000

(formerly: MetPath, Inc.).

CORNING National Center for Forensic

Science, 1901 Sulphur Spring Rd.,

Baltimore, MD 21227, 410–536–1485

(formerly: Maryland Medical

Laboratory, Inc., National Center for

Forensic Science).

CORNING Nichols Institute, 7470–A

Mission Valley Rd., San Diego, CA

92108–4406, 800–446–4728/619–686–

3200 (formerly: Nichols Institute,

Nichols Institute Substance Abuse

Testing (NISAT)).

Cox Medical Centers, Department of

Toxicology, 1423 North Jefferson

Ave., Springfield, MO 65802, 800–

876–3652/417–836–3093.

Dept. of the Navy, Navy Drug Screening

Laboratory, Great Lakes, IL, Building

38–H, Great Lakes, IL 60088–5223,

708–688–2045/708–688–4171.

Diagnostic Services Inc., dba DSI, 4048

Evans Ave., Suite 301, Fort Myers, FL

33901, 813–936–5446/800–735–5416.

Doctors Laboratory, Inc., P.O. Box 2658,

2906 Julia Dr., Valdosta, GA 31604,

912–244–4468.

Drug Labs of Texas, 15201 I–10 East,

Suite 125, Channelview, TX 77530,

713–457–3784.

DrugProof, Division of Dynacare/

Laboratory of Pathology, LLC, 1229

Madison St., Suite 500, Nordstrom

Medical Tower, Seattle, WA 98104,

800–898–0180/206–386–2672

(formerly: Laboratory of Pathology of

Seattle, Inc., DrugProof, Division of

Laboratory of Pathology of Seattle,

Inc.).

DrugScan, Inc., P.O. Box 2969, 1119

Mearns Rd., Warminster, PA 18974,

215–674–9310.

Eagle Forensic Laboratory, Inc., 950 N.

Federal Highway, Suite 308, Pompano

Beach, FL 33062, 305–946–4324.

ElSohly Laboratories, Inc., 5 Industrial

Park Dr., Oxford, MS 38655, 601–236–

2609.

General Medical Laboratories, 36 South

Brooks St., Madison, WI 53715, 608–

267–6267.

Harrison Laboratories, Inc., 9930 W.

Highway 80, Midland, TX 79706,

800–725–3784/915–563–3300,

(formerly: Harrison & Associates

Forensic Laboratories).

HealthCare/MetPath, 24451 Telegraph

Rd., Southfield, MI 48034, 800–444–

0106 ext. 650, (formerly: HealthCare/

Preferred Laboratories).

Holmes Regional Medical Center

Toxicology Laboratory, 5200 Babcock

St., NE., Suite 107, Palm Bay, FL

32905, 407–726–9920.

Jewish Hospital of Cincinnati, Inc., 3200

Burnet Ave., Cincinnati, OH 45229,

513–569–2051.

LabOne, Inc., 8915 Lenexa Dr., Overland

Park, Kansas 66214, 913–888–3927

(formerly: Center for Laboratory

Services, a Division of LabOne, Inc.).

Laboratory Specialists, Inc., 113 Jarrell

Dr., Belle Chasse, LA 70037, 504–

392–7961.

Marshfield Laboratories, 1000 North

Oak Ave., Marshfield, WI 54449, 715–

389–3734/800–222–5835.

MedExpress/National Laboratory

Center, 4022 Willow Lake Blvd.,

Memphis, TN 38175, 901–795–1515.

Medical College Hospitals Toxicology

Laboratory, Department of Pathology,

3000 Arlington Ave., Toledo, OH

43699–0008, 419–381–5213.

Medlab Clinical Testing, Inc., 212

Cherry Lane, New Castle, DE 19720,

302–655–5227.

MedTox Laboratories, Inc., 402 W.

County Rd. D, St. Paul, MN 55112,

800–832–3244/612–636–7466.

Methodist Hospital of Indiana, Inc.,

Department of Pathology and

Laboratory Medicine, 1701 N. Senate

Blvd., Indianapolis, IN 46202, 317–

929–3587.

Methodist Medical Center Toxicology

Laboratory, 221 N.E. Glen Oak Ave.,

Peoria, IL 61636, 800–752–1835/309–

671–5199.

MetPath Laboratories, 875 Greentree

Rd., 4 Parkway Ctr., Pittsburgh, PA

15220–3610, 412–931–7200 (formerly:

Med-Chek Laboratories, Inc., MedChek/Damon).

MetroLab-Legacy Laboratory Services,

235 N. Graham St., Portland, OR

97227, 503–413–4512, 800–237–

7808(x4512).

National Health Laboratories

Incorporated, 2540 Empire Dr.,

Winston-Salem, NC 27103–6710,

Outside NC: 919–760–4620/800–334–

8627/Inside NC: 800–642–0894.

National Health Laboratories

Incorporated, d.b.a. National

Reference Laboratory, Substance

Abuse Division, 1400 Donelson Pike,

Suite A–15, Nashville, TN 37217,

615–360–3992/800–800–4522.

National Health Laboratories

Incorporated, 13900 Park Center Rd.,

Herndon, VA 22071, 703–742–3100.

National Psychopharmacology

Laboratory, Inc., 9320 Park W. Blvd.,

Knoxville, TN 37923, 800–251–9492.

National Toxicology Laboratories, Inc.,

1100 California Ave., Bakersfield, CA

93304, 805–322–4250.

Northwest Toxicology, Inc., 1141 E.

3900 South, Salt Lake City, UT 84124,

800–322–3361.

Oregon Medical Laboratories, P.O. Box

972, 722 East 11th Ave., Eugene, OR

97440–0972, 503–687–2134.

Pathology Associates Medical

Laboratories, East 11604 Indiana,

Spokane, WA 99206, 509–926–2400.
16882 Federal Register / Vol. 60, No. 63 / Monday, April 3, 1995 / Notices

PDLA, Inc. (Princeton), 100 Corporate

Court, So. Plainfield, NJ 07080, 908–

769–8500/800–237–7352.

PharmChem Laboratories, Inc., 1505–A

O’Brien Dr., Menlo Park, CA 94025,

415–328–6200/800–446–5177.

PharmChem Laboratories, Inc., Texas

Division, 7606 Pebble Dr., Fort Worth,

TX 76118, 817–595–0294, (formerly:

Harris Medical Laboratory).

Physicians Reference Laboratory, 7800

West 110th St., Overland Park, KS

66210, 913–338–4070/800–821–3627,

(formerly: Physicians Reference

Laboratory Toxicology Laboratory).

Poisonlab, Inc., 7272 Clairemont Mesa

Rd., San Diego, CA 92111, 619–279–

2600/800–882–7272.

Puckett Laboratory, 4200 Mamie St.,

Hattiesburgh, MS 39402, 601–264–

3856/800–844–8378.

Regional Toxicology Services, 15305

N.E. 40th St., Redmond, WA 98052,

206–882–3400.

Roche Biomedical Laboratories, Inc.,

1120 Stateline Rd., Southaven, MS

38671, 601–342–1286.

Roche Biomedical Laboratories, Inc., 69

First Ave., Raritan, NJ 08869, 800–

437–4986.

Roche CompuChem Laboratories, Inc., A

Member of the Roche Group, 3308

Chapel Hill/Nelson Hwy., Research

Triangle Park, NC 27709, 919–549–

8263/800–833–3984, (Formerly:

CompuChem Laboratories, Inc., A

Subsidiary of Roche Biomedical

Laboratory).

Roche CompuChem Laboratories, Inc.,

Special Division, A Member of the

Roche Group, 3308 Chapel Hill/

Nelson Hwy., Research Triangle Park,

NC 27709, 919–549–8263, (Formerly:

CompuChem Laboratories, Inc.—

Special Division).

Scientific Testing Laboratories, Inc., 463

Southlake Blvd., Richmond, VA

23236, 804–378–9130.

Scott & White Drug Testing Laboratory,

600 S. 25th St., Temple, TX 76504,

800–749–3788.

S.E.D. Medical Laboratories, 500 Walter

NE, Suite 500, Albuquerque, NM

87102, 505–848–8800.

Sierra Nevada Laboratories, Inc., 888

Willow St., Reno, NV 89502, 800–

648–5472.

SmithKline Beecham Clinical

Laboratories, 7600 Tyrone Ave., Van

Nuys, CA 91045, 818–376–2520.

SmithKline Beecham Clinical

Laboratories, 801 East Dixie Ave.,

Leesburg, FL 34748, 904–787–9006,

(formerly: Doctors & Physicians

Laboratory).

SmithKline Beecham Clinical

Laboratories, 3175 Presidential Dr.,

Atlanta, GA 30340, 404–934–9205,

(formerly: SmithKline Bio-Science

Laboratories).

SmithKline Beecham Clinical

Laboratories, 506 E. State Pkwy.,

Schaumburg, IL 60173, 708–885–

2010, (formerly: International

Toxicology Laboratories).

SmithKline Beecham Clinical

Laboratories, 400 Egypt Rd.,

Norristown, PA 19403, 800–523–

5447, (formerly: SmithKline BioScience Laboratories).

SmithKline Beecham Clinical

Laboratories, 8000 Sovereign Row,

Dallas, TX 75247, 214–638–1301,

(formerly: SmithKline Bio-Science

Laboratories).

South Bend Medical Foundation, Inc.,

530 N. Lafayette Blvd., South Bend,

IN 46601, 219–234–4176.

Southwest Laboratories, 2727 W.

Baseline Rd., Suite 6, Tempe, AZ

85283, 602–438–8507.

St. Anthony Hospital (Toxicology

Laboratory), P.O. Box 205, 1000 N.

Lee St., Oklahoma City, OK 73102,

405–272–7052.

Toxicology & Drug Monitoring

Laboratory, University of Missouri

Hospital & Clinics, 301 Business Loop

70 West, Suite 208, Columbia, MO

65203, 314–882–1273.

Toxicology Testing Service, Inc., 5426

N.W. 79th Ave., Miami, FL 33166,

305–593–2260.

TOXWORX Laboratories, Inc., 6160

Variel Ave., Woodland Hills, CA

91367, 818–226–4373, (formerly:

Laboratory Specialists, Inc.; Abused

Drug Laboratories; MedTox BioAnalytical, a Division of MedTox

Laboratories, Inc.).

UNILAB, 18408 Oxnard St., Tarzana,

CA 91356, 800–492–0800/818–343–

8191, (formerly: MetWest-BPL

Toxicology Laboratory).

No laboratories withdrew from the

Program in March.

Richard Kopanda,

Acting Executive Officer Substance Abuse

and Mental Health Services Administration.

[FR Doc. 95–8015 Filed 3–31–95; 8:45 am]

BILLING CODE 4160–20–U

DEPARTMENT OF THE INTERIOR

Fish and Wildlife Service

[PRT–800377]

Receipt of Application(s) for Permit

The following applicant has applied

for a permit to conduct certain activities

with endangered species. This notice is

provided pursuant to Section 10(c) of

the Endangered Species Act of 1973, as

amended (16 U.S.C. 1531, et seq.).

Applicant: Loreen Allphin, Biology

Department, University of Utah, Salt

Lake City, Utah.

The applicant requests a permit to

include collect fruits of the Sentry milkvetch (Astragalus cremnophalax var.

cremnophalax) and Mancos milk-vetch

(Astragalus humillimus) for the purpose

of scientific research and enhancement

of propagation and survival of the

species as prescribed by Service

recovery documents.

ADDRESSES: Written data or comments

should be submitted to the Assistant

Regional Director, Ecological Services,

U.S. Fish and Wildlife Service, P.O. Box

1306, Albuquerque, New Mexico 87103,

and must be received by the Assistant

Regional Director within 30 days from

the date of this publication.

Documents and other information

submitted with this application are

available for review, subject to the

requirements of the Privacy Act and

Freedom of Information Act, by any

party who submits a written request for

a copy of such documents to the above

office within 30 days of the date of

publication of this notice. (See

ADDRESSES above.)

James A. Young,

Acting Regional Director, Region 2,

Albuquerque, New Mexico.

[FR Doc. 95–8073 Filed 3–31–95; 8:45 am]

BILLING CODE 4310–55–M

[PRT–800458]

Receipt of Application(s) for Permit

The following applicant has applied

for a permit to conduct certain activities

with endangered species. This notice is

provided pursuant to Section 10(c) of

the Endangered Species Act of 1973, as

amended (16 U.S.C. 1531, et seq.)

Applicant: Mark D. Hovorka,

Department of Biology, York University,

North York, Ontario, Canada.

The applicant requests a permit to

include take of the lesser long-nosed bat

(Leptonycteris curasoae yerbabuenae)

for the purpose of scientific research

and enhancement of propagation and

survival of the species as prescribed by

Service recovery documents.

ADDRESSES: Written data or comments

should be submitted to the Assistant

Regional Director, Ecological Services,

U.S. Fish and Wildlife Service, P.O. Box

1306, Albuquerque, New Mexico 87103,

and must be received by the Assistant

Regional Director within 30 days from

the date of this publication.

Documents and other information

submitted with this application are

available for review, subject to the

requirements of the Privacy Act and

Freedom of Information Act, by any

party who submits a written request for

a copy of such documents to the above